Rankle 发表于 2025-3-25 05:43:56

http://reply.papertrans.cn/1/67/6655/6655-21.png

frugal 发表于 2025-3-25 10:11:28

http://reply.papertrans.cn/1/67/6655/6655-22.png

LAP 发表于 2025-3-25 11:40:51

http://reply.papertrans.cn/1/67/6655/6655-23.png

变异 发表于 2025-3-25 19:42:31

Submitted on: 23 November 2010.
Revised on: 19 February 2011.
Accepted on: 21 March 2011.

___________________CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

来自于 发表于 2025-3-25 21:40:45

http://reply.papertrans.cn/1/67/6655/6655-25.png

Infirm 发表于 2025-3-26 03:19:10

Submitted on: 12 May 2019.
Revised on: 29 August 2019.
Accepted on: 25 September 2019.

___________________CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

夜晚 发表于 2025-3-26 05:58:42

Submitted on: 15 December 2010.
Revised on: 14 March 2011.
Accepted on: 04 May 2011.

___________________CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

gonioscopy 发表于 2025-3-26 08:27:51

Submitted on: 07 June 2013.
Revised on: 21 July 2013.
Accepted on: 31 August 2013.

___________________CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

oxidize 发表于 2025-3-26 14:06:53

http://reply.papertrans.cn/1/67/6655/6655-29.png

熔岩 发表于 2025-3-26 19:50:13

http://reply.papertrans.cn/1/67/6655/6655-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 2024/2025影响因子:3.139 (CRIT REV THER DRUG) (0743-4863). (PHARM